I know you are not ER. For the TO, it looked like most that exercised were probably older, higher price, close to expiration. The announcement dropped the sp to 40c, so they probably thought extending it would not be beneficial right now. It would drop the price back to 40c and they wouldn’t get additional money. For news, firming up the BLA timeline especially if the fda accepts 525mg with Combo, is probably the next big news. NP maybe in DC last week from what some thought was the hotel, maybe he was talking about the safety data. He did say they should know soon. Anyway, Mono pivotal is a month or more away. mTNBC shots probably starts this month with a little bump, but we will wait for results to get the big boost imo. So combo probably will be next.
The funny thing is I remember not getting updates for months and people complaining( I was one), now we get updates weekly with some people now are complaining it is a waist of money... I personally like it now way more than before.

There is a possibility we get new info about the safety data needed next week. CYDY presenting phase 3 final results might get a little publicity, with the oral presentation and so close to approval now. As I posted earlier, it did make the list of what is happening in biotech next week, but what gets picked up by media is unpredictable.